Arkolith/Insider Trading/TMDX/Form 4

Weill David

DirectorTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Dec 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$693K
Net Open-Market Flow
-$693K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2025Option exercise(M)5K$14.20$71K17K
Dec 3, 2025Sell(S)5K$138.64$693K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 3, 2025Option exercise(M)5K—$05K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-309751) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML